Lee KWC - Search Results

1

Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease.

Li MSC, Lee KWC, Mok KKS, Loong HHF, Lam KC, Mok FST, Chan LL, Lau YM, Chan KP, Ng JTY, Wong WKY, Lam BHW, Chen ACC, Lee MMP, Chen OH, Mok TSK. Li MSC, et al. Among authors: lee kwc. JTO Clin Res Rep. 2024 Feb 10;5(4):100648. doi: 10.1016/j.jtocrr.2024.100648. eCollection 2024 Apr. JTO Clin Res Rep. 2024. PMID: 38590729 Free PMC article.

2

Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non-Small Cell Lung Cancer.

Lee KWC, Li MSC, Gai W, Lau YM, Chan AKC, Chan OSH, Lee CK, Yeung RMW, Fung SYH, Cheung WF, Chan VW, Leung L, Kam KNP, Mok TSK. Lee KWC, et al. JAMA Oncol. 2023 Feb 1;9(2):261-265. doi: 10.1001/jamaoncol.2022.6109. JAMA Oncol. 2023. PMID: 36580285 Free PMC article.

3

Can Quantitative Measures of T790M Allelic Fraction Predict Survival Outcomes in Patients Receiving Osimertinib? Observations From an Early Access Programme.

Chan OSH, Lee VHF, Nyaw SF, Kam MTY, Lee KWC, Lam KC. Chan OSH, et al. Among authors: lee kwc. Clin Oncol (R Coll Radiol). 2021 Jul;33(7):e305-e314. doi: 10.1016/j.clon.2021.01.011. Epub 2021 Feb 12. Clin Oncol (R Coll Radiol). 2021. PMID: 33589348

4

Erlotinib in metastatic bronchopulmonary mucoepidermoid carcinoma.

Lee KW, Chan AB, Lo AW, Lam KC. Lee KW, et al. J Thorac Oncol. 2011 Dec;6(12):2140-1. doi: 10.1097/JTO.0b013e318237746a. J Thorac Oncol. 2011. PMID: 22088991 Free article. No abstract available.

5

Oral appliance-generated malocclusion traits during the long-term management of obstructive sleep apnea in adults.

Karadeniz C, Lee KWC, Lindsay D, Karadeniz EI, Flores-Mir C. Karadeniz C, et al. Among authors: lee kwc. Angle Orthod. 2022 Mar 1;92(2):255-264. doi: 10.2319/041921-316.1. Angle Orthod. 2022. PMID: 34929027 Free PMC article.

6

The impact of smoking on the effectiveness of immune checkpoint inhibitors - a systematic review and meta-analysis.

Lee KWC, Lord SJ, Kasherman L, Marschner I, Stockler M, Gralla R, Yang JC, Mok T, Lee CK. Lee KWC, et al. Acta Oncol. 2020 Jan;59(1):96-100. doi: 10.1080/0284186X.2019.1670354. Epub 2019 Sep 25. Acta Oncol. 2020. PMID: 31552770 No abstract available.

7

Efficacy of immune checkpoint inhibitors in older adults with advanced stage cancers: A meta-analysis.

Kasherman L, Siu DHW, Lee KWC, Lord S, Marschner I, Lewis CR, Friedlander M, Lee CK. Kasherman L, et al. Among authors: lee kwc. J Geriatr Oncol. 2020 Apr;11(3):508-514. doi: 10.1016/j.jgo.2019.05.013. Epub 2019 May 23. J Geriatr Oncol. 2020. PMID: 31129081

8

The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis.

Lee KWC, Lord S, Finn RS, Lim E, Martin A, Loi S, Lynch J, Friedlander M, Lee CK. Lee KWC, et al. Breast Cancer Res Treat. 2019 Feb;174(1):271-278. doi: 10.1007/s10549-018-5054-x. Epub 2018 Nov 21. Breast Cancer Res Treat. 2019. PMID: 30465154

9

Hepatotoxicity of targeted therapy for cancer.

Lee KW, Chan SL. Lee KW, et al. Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):789-802. doi: 10.1080/17425255.2016.1190831. Epub 2016 Jun 6. Expert Opin Drug Metab Toxicol. 2016. PMID: 27187715 Review.

10

Piperacillin/tazobactam Induced Myelosuppression.

Lee KW, Chow KM, Chan NP, Lo AO, Szeto CC. Lee KW, et al. J Clin Med Res. 2009 Apr;1(1):53-5. doi: 10.4021/jocmr2009.03.1227. Epub 2009 Mar 24. J Clin Med Res. 2009. PMID: 22505967 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page